RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
8.43
-1.30 (-13.36%)
At close: Jun 27, 2025, 4:00 PM
8.42
-0.01 (-0.12%)
After-hours: Jun 27, 2025, 6:58 PM EDT
RAPT Therapeutics Employees
RAPT Therapeutics had 68 employees as of December 31, 2024. The number of employees decreased by 63 or -48.09% compared to the previous year.
Employees
68
Change (1Y)
-63
Growth (1Y)
-48.09%
Revenue / Employee
n/a
Profits / Employee
-$1,713,368
Market Cap
139.40M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
RAPT News
- 5 days ago - RAPT Therapeutics Names Two Industry Veterans to its Board of Directors - GlobeNewsWire
- 15 days ago - RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split - GlobeNewsWire
- 23 days ago - RAPT Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - RAPT Therapeutics Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development - GlobeNewsWire
- 4 months ago - RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 6 months ago - RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 months ago - RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company's Board of Directors - GlobeNewsWire